Tag: TCT 2017

TCT 2017: The HREVS study provides supportive evidence for the hybrid revascularisation approach

The HREVS (Hybrid coronary revascularisation vs. standard) trial found that there was no signifi...

TCT 2017: FAME 2 provides support for PCI in stable disease after ORBITA

Following ORBITA, which indicated percutaneous coronary intervention (PCI) did not provide benef...

TCT 2017: Advances in device technology needed to improve outcomes with Absorb

Data from the ABSORB IV study indicate that device thrombosis with the bioresorbable vascular sc...

Interventional cardiology in the Twitterverse

The past few years has witnessed increasing clinician engagement with social media platforms, in...

TCT 2017: TMVI in mitral ring is a reasonable alternative for high-risk patients

Data from the MITRAL (Mitral Implantation of Transcatheter valves) study indicate that transepta...

A bold new study could alter the orbit of elective PCI

The ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplas...

TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI for stable angina

ORBITA (Objective randomised blinded investigation with optimal medical therapy of angioplasty i...

TCT 2017: Study challenges recommendations on the management of cardiogenic shock

Advice on percutaneous coronary intervention (PCI) strategies for patients with acute myocardial...

TCT 2017: Elixir reveals new drug-eluting stent

Elixir Medical unveiled for the first time its novel stent technology—Dynamx—at the 2017 Transca...

TCT 2017: Pooled analysis of Magmaris studies continue to show no instances of scaffold thrombosis at 12 months

Data presented during the 2017 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 Octob...

TCT 2017: Next-generation FFR system launched

Acist has announced the global launch of its RXi Mini system—the next-generation system of its RXi R...

TCT 2017: No advantage with extending dual antiplatelet therapy beyond six months in STEMI patients

The primary results from the DAPT-STEMI trial suggest that 12-month dual antiplatelet therapy (D...

TCT 2017: Fantom bioresorbable scaffold continues to show positive outcomes at two years

The Fantom bioresorbable scaffold (Reva Medical) shows continued positive clinical outcomes acco...

TCT 2017: Two studies support feasibility of transcatheter mitral valve implantation

Early experiences with two transcatheter mitral valve implantation (TMVI) devices—Intrepid (Medt...

TCT 2017: No role for bare metal stents to reduce duration of dual antiplatelet therapy in older patients

Olivier Varenne (Hôpital Cochin, Assistance Publique—Hôpitaux De Paris, Paris, France) reported ...

TCT 2017: TAVI “should be the preferred strategy” for patients at intermediate-risk

David Cohen (Saint Luke’s Mid America Heart Institute, Kansas City, USA) has suggested that, on ...

TCT 2017: New data for CoreValve Evolut further support its use in intermediate-risk patients  

New clinical research, presented today at the 2017 Transcatheter Cardiovascular Therapeutics (TCT)...

TCT 2017: Combo dual-therapy stent is non-inferior to Xience at one year

New results from the HARMONEE Japan/US registration trial, which were presented yesterday at the 2...

TCT 2017: Data for novel cardiac imaging technology unveiled

New data from the ongoing CADLAD (Coronary artery disease learning and algorithm development) study ...

TCT 2017: AI-driven cardiac ultrasound company to give two presentations

Bay Labs, a medical technology company developing an artificial intelligence in cardiovascular imagi...

Cobra PzF nano-coated stent now being studied with 14-day DAPT in patients at high risk of bleeding

The US FDA has approved the expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra ...

TCT 2017: Boston Scientific reveals presentations at conference

Boston Scientific has announced key data will be presented at next week’s Transcatheter Cardiova...

TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent platform”

Elixir Medical has revealed details of its programme and activities during the 2017 meeting of the t...

TCT 2017: Alec Vahanian to receive the Master Clinical Operator award

The Geoffrey O. Hartzler Master Clinical Operator Award will be presented to Alec Vahanian (Cardiolo...

TCT 2017: Cardiovascular Research Foundation announces late-breaking trials and first-report investigations

The Cardiovascular Research Foundation (CRF) has release details of the 12 late-breaking trials ...